Article

Angiogenesis 2023: GA phenotypes and progression rates in Asians vs non-Asians

Author(s):

A study conducted by Gemmy Cheung, MBBS, FRCOphth and colleagues shows geographic atrophy (GA) lesion phenotypes, associated features, and growth rates differ between Asians and non-Asians.

Gemmy Cheung, MBBS, FRCOphth, and her colleagues conducted a multicenter retrospective cohort study that directly compared Asian and non-Asian patients to characterize GA and pinpoint specific differences between the ethnic groups.

Gemmy Cheung, MBBS, FRCOphth, and her colleagues conducted a multicenter retrospective cohort study that directly compared Asian and non-Asian patients to characterize GA and pinpoint specific differences between the ethnic groups.

Geographic atrophy (GA) lesion phenotypes, associated features, and growth rates differ between Asians and non-Asians, Gemmy Cheung, MBBS, FRCOphth, reported at the Angiogenesis, Exudation, and Degeneration meeting in Miami.

She is the Arthur Lim Professor in Ophthalmology, Duke-National University of Singapore Medical School, National University of Singapore Head, Medical Retina Department, Singapore National Eye Centre, and Head, Retina Research Group, Singapore Eye Research Institute, Singapore.

She and her colleagues conducted a multicenter retrospective cohort study1 that directly compared Asian and non-Asian patients to characterize GA and pinpoint specific differences between the ethnic groups.

Participants included in the study were 50 years and older with GA secondary to age-related macular degeneration and had been followed for 2 years or longer.

A total of 144 patients (169 eyes) were included. The 2 groups were similar in age and gender and fairly evenly divided by ethnicity.

The analysis showed numerous significant differences in GA characteristics between the groups.

The choroids in Asians were thicker (167±74 μm vs 134±56 μm, p<0.01) and the lower prevalence of drusen was lower (40.7% vs 66.3%, p<0.01).

The baseline GA area was smaller in Asians vs non-Asians (by near infrared imaging [NIR], 3.7±4.6 mm2 vs 6.3±6.8 mm2, p=0.01; by fundus autofluorescence, [FAF] 2.4±3.4 mm2 vs 8.4±9.6 mm2, p<0.01). Fewer GA foci were seen in Asians (1.7±1.3 vs 2.7±2.2, p<0.01) compared to non-Asians.

The proportion with diffuse/banded FAF junctional zone patterns was similar between Asians and non-Asians (44.2% vs 60.2%, p=0.20).

GA lesion growth was slower in Asians compared to non-Asians (NIR, 0.7 vs 1.9 mm2/year, p<0.01; FAF, 0.3 vs 2.0 mm2/year, p<0.01; NIR 0.4 vs 0.9 mm/year, p<0.001 square root transformed; FAF, 0.3 vs 1.0 mm/year, p<0.001 square root transformed).

Ethnicity, junctional zone FAF pattern, baseline GA area, and number of GA foci were associated with the growth rate of GA lesions in descending order of importance.

Eyes with baseline lesions that were 5 mm2 or greater showed the highest growth rate and difference between ethnicities was no longer significant. (2.6 vs 3.3 mm2/year, p=0.09)

The study take-home messages were that:

• The GA phenotypes in Asians compared to non-Asians were smaller lesion area, fewer foci, less bilateral GA at baseline

• Asians have with thicker choroid and fewer drusen

•The growth rate of GA is slower in Asians compared to non-Asians 0.7 vs 2.0 mm2/year; 0.4 vs 0.9 mm/year square root transformed

• Faster progression in Asians is associated with the baseline lesion area and higher number of foci and in non-Asians with a diffuse/banded FAF pattern

Reference
1. Teo K Yc, Fujimoto S, Sadda SR, et al. Geographic atrophy phenotypes in subjects of different ethnicity: Asia-Pacific Ocular Imaging Society Workgroup Report 3. Ophthalmol Retina. 2022;S2468-6530(22)00639-X. doi: 10.1016/j.oret.2022.12.013.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.